NL-OMON22245已完成不适用
HIgh-dose baclofen for the treatment of alcohol addiction: A double-blind, randomized, placebo-controlled study.
Academisch Medisch Centrum (AMC)0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male and Female patients, aged between 18-60 years;
- •2. Participants have a current DSM-IV diagnosis of alcohol dependence;
排除标准
- •1. Participants with current severe psychiatric disorders (schizophrenia, schizoaffective disorder,bulimia/anorexia, or ADHD requiring medication) besides depression, bipolar disorder and anxiety;
- •2. Participants with serious medical illnesses (Parkison’s disease, gastric ulcer, duodenal ulcer, cerebrovascular disease, respiratory insufficiency, hepatic or renal insufficiency, and epilepsy);
研究者
相似试验
已完成
3 期
High-dose baclofen for the treatment of alcohol addiction * A double-blind, randomized, placebo-controlled studyverslavingaddictionNL-OMON41310Academisch Medisch Centrum130
进行中（未招募）
不适用
High-dose baclofen for the treatment of alcohol addictioAlcohol dependenceEUCTR2011-004142-17-NLAcademic Medical Centrum250
进行中（未招募）
不适用
Baclofen for the Treatment of Alcohol Dependence - BACLADAlcohol DependenceEUCTR2010-021861-62-DECharité - Universitätsmedizin Berlin
Unknown
4 期
Baclofen in Managing Acute Alcohol WithdrawalAlcohol Use DisorderAlcohol WithdrawalNCT03293017Universitair Ziekenhuis Brussel90
已完成
4 期
Baclofen as Add-On to Standard Treatment of Alcohol- Dependent PatientsAlcohol DependenceNCT01002105Sha'ar Menashe Mental Health Center75